Global Anti-Migraine Drugs Market Insights and Forecast to 2026

Global Anti-Migraine Drugs Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Migraine Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Migraine Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Migraine Drugs Market Size Growth Rate by Type
1.4.2 Triptans
1.4.3 Ergots
1.4.4 Others
1.5 Market by Application
1.5.1 Global Anti-Migraine Drugs Market Size Growth Rate by Application
1.5.2 Women
1.5.3 Men
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Migraine Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Migraine Drugs Revenue 2015-2026
2.1.2 Global Anti-Migraine Drugs Sales 2015-2026
2.2 Global Anti-Migraine Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Migraine Drugs Competitor Landscape by Players
3.1 Anti-Migraine Drugs Sales by Manufacturers
3.1.1 Anti-Migraine Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Migraine Drugs Revenue by Manufacturers
3.2.1 Anti-Migraine Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Migraine Drugs Revenue in 2019
3.2.5 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Migraine Drugs Price by Manufacturers
3.4 Anti-Migraine Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Migraine Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Migraine Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Migraine Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Migraine Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Migraine Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Migraine Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Migraine Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Migraine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Migraine Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Migraine Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Migraine Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Migraine Drugs Price by Application (2015-2020)
5.2 Anti-Migraine Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Migraine Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Migraine Drugs by Country
6.1.1 North America Anti-Migraine Drugs Sales by Country
6.1.2 North America Anti-Migraine Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Migraine Drugs Market Facts & Figures by Type
6.3 North America Anti-Migraine Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Migraine Drugs by Country
7.1.1 Europe Anti-Migraine Drugs Sales by Country
7.1.2 Europe Anti-Migraine Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Migraine Drugs Market Facts & Figures by Type
7.3 Europe Anti-Migraine Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Migraine Drugs by Region
8.1.1 Asia Pacific Anti-Migraine Drugs Sales by Region
8.1.2 Asia Pacific Anti-Migraine Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Migraine Drugs by Country
9.1.1 Latin America Anti-Migraine Drugs Sales by Country
9.1.2 Latin America Anti-Migraine Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Migraine Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-Migraine Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Migraine Drugs by Country
10.1.1 Middle East and Africa Anti-Migraine Drugs Sales by Country
10.1.2 Middle East and Africa Anti-Migraine Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Description and Business Overview
11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Anti-Migraine Drugs Products Offered
11.2.5 Abbott Laboratories Related Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Description and Business Overview
11.3.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eisai Anti-Migraine Drugs Products Offered
11.3.5 Eisai Related Developments
11.4 Allergan
11.4.1 Allergan Corporation Information
11.4.2 Allergan Description and Business Overview
11.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Allergan Anti-Migraine Drugs Products Offered
11.4.5 Allergan Related Developments
11.5 Endo
11.5.1 Endo Corporation Information
11.5.2 Endo Description and Business Overview
11.5.3 Endo Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Endo Anti-Migraine Drugs Products Offered
11.5.5 Endo Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Impax Laboratories
11.7.1 Impax Laboratories Corporation Information
11.7.2 Impax Laboratories Description and Business Overview
11.7.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
11.7.5 Impax Laboratories Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Anti-Migraine Drugs Products Offered
11.8.5 Pfizer Related Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Description and Business Overview
11.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
11.9.5 AstraZeneca Related Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Description and Business Overview
11.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bayer Anti-Migraine Drugs Products Offered
11.10.5 Bayer Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.12 Merck
11.12.1 Merck Corporation Information
11.12.2 Merck Description and Business Overview
11.12.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Merck Products Offered
11.12.5 Merck Related Developments
11.13 Teva
11.13.1 Teva Corporation Information
11.13.2 Teva Description and Business Overview
11.13.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Teva Products Offered
11.13.5 Teva Related Developments
11.14 Amgen
11.14.1 Amgen Corporation Information
11.14.2 Amgen Description and Business Overview
11.14.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Amgen Products Offered
11.14.5 Amgen Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Migraine Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-Migraine Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Migraine Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Migraine Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Migraine Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Migraine Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Migraine Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Migraine Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Migraine Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Migraine Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Migraine Drugs Market Segments
Table 2. Ranking of Global Top Anti-Migraine Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Migraine Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Triptans
Table 5. Major Manufacturers of Ergots
Table 6. Major Manufacturers of Others
Table 7. Global Anti-Migraine Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-Migraine Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Migraine Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Migraine Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Migraine Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Anti-Migraine Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2019)
Table 16. Anti-Migraine Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-Migraine Drugs Price (2015-2020) (USD/Pcs)
Table 19. Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-Migraine Drugs Product Type
Table 21. Date of International Manufacturers Enter into Anti-Migraine Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Anti-Migraine Drugs Sales Share by Type (2015-2020)
Table 25. Global Anti-Migraine Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-Migraine Drugs Revenue Share by Type (2015-2020)
Table 27. Anti-Migraine Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Anti-Migraine Drugs Sales Share by Application (2015-2020)
Table 30. North America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-Migraine Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-Migraine Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-Migraine Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Migraine Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-Migraine Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Major Businesses
Table 72. Eli Lilly Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. Eli Lilly Product
Table 74. Eli Lilly Recent Development
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Major Businesses
Table 77. Abbott Laboratories Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Abbott Laboratories Product
Table 79. Abbott Laboratories Recent Development
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Major Businesses
Table 82. Eisai Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Eisai Product
Table 84. Eisai Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Major Businesses
Table 87. Allergan Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Allergan Product
Table 89. Allergan Recent Development
Table 90. Endo Corporation Information
Table 91. Endo Description and Major Businesses
Table 92. Endo Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Endo Product
Table 94. Endo Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Impax Laboratories Corporation Information
Table 101. Impax Laboratories Description and Major Businesses
Table 102. Impax Laboratories Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Impax Laboratories Product
Table 104. Impax Laboratories Recent Development
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Pfizer Product
Table 109. Pfizer Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Major Businesses
Table 112. AstraZeneca Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. AstraZeneca Product
Table 114. AstraZeneca Recent Development
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Anti-Migraine Drugs Production (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Bayer Product
Table 119. Bayer Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Major Businesses
Table 122. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Johnson & Johnson Product
Table 124. Johnson & Johnson Recent Development
Table 125. Merck Corporation Information
Table 126. Merck Description and Major Businesses
Table 127. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Merck Product
Table 129. Merck Recent Development
Table 130. Teva Corporation Information
Table 131. Teva Description and Major Businesses
Table 132. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Teva Product
Table 134. Teva Recent Development
Table 135. Amgen Corporation Information
Table 136. Amgen Description and Major Businesses
Table 137. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Amgen Product
Table 139. Amgen Recent Development
Table 140. Global Anti-Migraine Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Anti-Migraine Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Anti-Migraine Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Anti-Migraine Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Anti-Migraine Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Anti-Migraine Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Anti-Migraine Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Anti-Migraine Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Anti-Migraine Drugs Players
Table 158. Anti-Migraine Drugs Customers List
Table 159. Anti-Migraine Drugs Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Migraine Drugs Product Picture
Figure 2. Global Anti-Migraine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Triptans Product Picture
Figure 4. Ergots Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Migraine Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Women
Figure 8. Men
Figure 9. Anti-Migraine Drugs Report Years Considered
Figure 10. Global Anti-Migraine Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Migraine Drugs Sales 2015-2026 (K Units)
Figure 12. Global Anti-Migraine Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Anti-Migraine Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Anti-Migraine Drugs Sales Market Share by Region in 2019
Figure 15. Global Anti-Migraine Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Anti-Migraine Drugs Revenue Market Share by Region in 2019
Figure 17. Global Anti-Migraine Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2019
Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Anti-Migraine Drugs Sales Market Share by Type in 2019
Figure 22. Global Anti-Migraine Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Type in 2019
Figure 24. Global Anti-Migraine Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Anti-Migraine Drugs Sales Market Share by Application in 2019
Figure 27. Global Anti-Migraine Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Anti-Migraine Drugs Revenue Market Share by Application in 2019
Figure 29. North America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 32. North America Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Anti-Migraine Drugs Market Share by Type in 2019
Figure 38. North America Anti-Migraine Drugs Market Share by Application in 2019
Figure 39. Europe Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 42. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Anti-Migraine Drugs Market Share by Type in 2019
Figure 54. Europe Anti-Migraine Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region in 2019
Figure 59. China Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Anti-Migraine Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Anti-Migraine Drugs Market Share by Application in 2019
Figure 83. Latin America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Anti-Migraine Drugs Market Share by Type in 2019
Figure 94. Latin America Anti-Migraine Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Anti-Migraine Drugs Market Share by Type in

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Narcolepsy Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80

According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......

Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......

Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......

Migraine Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......

Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......

Global Edaravone Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......

Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......

Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs